Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

Titanflow improves male urinary health by strengthening the detrusor muscle and enhancing urine flow.

Intralesional triamcinolone acetonide helps regrow eyebrows in patients with frontal fibrosing alopecia.

Stopping tight hairstyles can prevent and reduce traction alopecia.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

TECAR therapy helps with pain relief, reduces inflammation, relaxes muscles, heals tissues, and is safe and effective for many conditions.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Recombinant human TSG-6 speeds up wound healing in diabetic mice.

Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.

Testosterone and finasteride improve body composition in men with spinal cord injury.

Method accurately measures finasteride and tamsulosin in combined drug form.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The hair tonic from Usada Bali plants increased hair growth without irritating the skin.

Phosphorylation controls TFEB's location in the cell, affecting cell metabolism and stress response.

Ginger hair tonic can reduce hair loss and improve hair quality.

The new testosterone patch works as well as the gel.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

Alfatradiol (0.025%) is an effective and safe treatment for hair loss in both women and men.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Tadalafil may reduce the risk of major heart events and blood clots in men with urinary symptoms.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

A young cat had a rare hair condition with twisted hair shafts but stayed healthy.

Primary care should recognize and treat hair loss in hijab-wearing individuals with cultural sensitivity.